Tercica To Pursue Development Of Nutropin AQ/Increlex Combination Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with Genentech calls for development of drugs for short stature, adult growth hormone deficiency and potentially metabolic disorders.